FDA Approved: FERRLECIT — Supplemental Application (sanofi-aventis U.S. LLC)

View source ↗

Summary

The FDA approved a supplemental application for Ferrlecit (sodium ferric gluconate complex) submitted by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• FERRLECIT (SODIUM FERRIC GLUCONATE COMPLEX)

Snippet

SUPPL AP for FERRLECIT (SODIUM FERRIC GLUCONATE COMPLEX)